| BIOMARKER INFORMATION | |
|---|---|
Biomarker |
CD26 |
Category |
Molecular Changes |
Affected targets |
Liver Aging |
Hallmarks |
Cellular Senescence |
Molecular |
Protein |
Description |
Samples enriched in CD26high MSC(AT) have reduced immunopotency and CD26high MSCs are reduced with senolytics. |
| EXPERIMENT INFORMATION | |
Region |
/ |
Race |
/ |
Samples |
14 |
Age |
68.6/16/7 |
Gender |
45480 |
Application |
Predictive |
Conclusion |
Our findings support cd26 surface abundance as a promising marker to assess the quality of msc(at) for clinical applications. |
Reference |
Inés Colmegna, Stem Cell Res Ther, 2022 |
Details |
PMID:35883188 (Click to Pubmed) ； IF: ； Citation: |
Confidence |